170 related articles for article (PubMed ID: 17145757)
1. Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells.
Lin H; Chen MC; Chiu CY; Song YM; Lin SY
J Biol Chem; 2007 Feb; 282(5):2776-84. PubMed ID: 17145757
[TBL] [Abstract][Full Text] [Related]
2. RET Regulates Human Medullary Thyroid Cancer Cell Proliferation through CDK5 and STAT3 Activation.
Yue CH; Oner M; Chiu CY; Chen MC; Teng CL; Wang HY; Hsieh JT; Lai CH; Lin H
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207842
[TBL] [Abstract][Full Text] [Related]
3. Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells.
Hsu FN; Chen MC; Lin KC; Peng YT; Li PC; Lin E; Chiang MC; Hsieh JT; Lin H
Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E975-86. PubMed ID: 23941877
[TBL] [Abstract][Full Text] [Related]
4. The role of Cdk5 in neuroendocrine thyroid cancer.
Pozo K; Castro-Rivera E; Tan C; Plattner F; Schwach G; Siegl V; Meyer D; Guo A; Gundara J; Mettlach G; Richer E; Guevara JA; Ning L; Gupta A; Hao G; Tsai LH; Sun X; Antich P; Sidhu S; Robinson BG; Chen H; Nwariaku FE; Pfragner R; Richardson JA; Bibb JA
Cancer Cell; 2013 Oct; 24(4):499-511. PubMed ID: 24135281
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of cell cycle regulators in CDK5-dependent medullary thyroid carcinoma tumorigenesis.
Pozo K; Hillmann A; Augustyn A; Plattner F; Hai T; Singh T; Ramezani S; Sun X; Pfragner R; Minna JD; Cote GJ; Chen H; Bibb JA; Nwariaku FE
Oncotarget; 2015 May; 6(14):12080-93. PubMed ID: 25900242
[TBL] [Abstract][Full Text] [Related]
6. Targeting STAT3/miR-21 axis inhibits epithelial-mesenchymal transition via regulating CDK5 in head and neck squamous cell carcinoma.
Sun SS; Zhou X; Huang YY; Kong LP; Mei M; Guo WY; Zhao MH; Ren Y; Shen Q; Zhang L
Mol Cancer; 2015 Dec; 14():213. PubMed ID: 26690371
[TBL] [Abstract][Full Text] [Related]
7. Quantitative measurement of in vivo phosphorylation states of Cdk5 activator p35 by Phos-tag SDS-PAGE.
Hosokawa T; Saito T; Asada A; Fukunaga K; Hisanaga S
Mol Cell Proteomics; 2010 Jun; 9(6):1133-43. PubMed ID: 20097924
[TBL] [Abstract][Full Text] [Related]
8. The Cdk5/p35 kinases modulate leptin-induced STAT3 signaling.
He Y; Kastin AJ; Hsuchou H; Pan W
J Mol Neurosci; 2009 Sep; 39(1-2):49-58. PubMed ID: 19156541
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines.
Farina FM; Inguscio A; Kunderfranco P; Cortesi A; Elia L; Quintavalle M
Cell Death Dis; 2017 Jun; 8(6):e2890. PubMed ID: 28640256
[TBL] [Abstract][Full Text] [Related]
10. p35/Cyclin-dependent kinase 5 is required for protection against beta-amyloid-induced cell death but not tau phosphorylation by ceramide.
Seyb KI; Ansar S; Li G; Bean J; Michaelis ML; Dobrowsky RT
J Mol Neurosci; 2007; 31(1):23-35. PubMed ID: 17416967
[TBL] [Abstract][Full Text] [Related]
11. Regulation of androgen receptor and prostate cancer growth by cyclin-dependent kinase 5.
Hsu FN; Chen MC; Chiang MC; Lin E; Lee YT; Huang PH; Lee GS; Lin H
J Biol Chem; 2011 Sep; 286(38):33141-9. PubMed ID: 21799006
[TBL] [Abstract][Full Text] [Related]
12. The cdk5 kinase regulates the STAT3 transcription factor to prevent DNA damage upon topoisomerase I inhibition.
Courapied S; Sellier H; de Carné Trécesson S; Vigneron A; Bernard AC; Gamelin E; Barré B; Coqueret O
J Biol Chem; 2010 Aug; 285(35):26765-26778. PubMed ID: 20516069
[TBL] [Abstract][Full Text] [Related]
13. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
Hisanaga S; Saito T
Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
[TBL] [Abstract][Full Text] [Related]
14. Suppression of calpain-dependent cleavage of the CDK5 activator p35 to p25 by site-specific phosphorylation.
Kamei H; Saito T; Ozawa M; Fujita Y; Asada A; Bibb JA; Saido TC; Sorimachi H; Hisanaga S
J Biol Chem; 2007 Jan; 282(3):1687-94. PubMed ID: 17121855
[TBL] [Abstract][Full Text] [Related]
15. IFI16 is an essential mediator of growth inhibition, but not differentiation, induced by the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells.
Kim EJ; Park JI; Nelkin BD
J Biol Chem; 2005 Feb; 280(6):4913-20. PubMed ID: 15572361
[TBL] [Abstract][Full Text] [Related]
16. Future Aspects of CDK5 in Prostate Cancer: From Pathogenesis to Therapeutic Implications.
Oner M; Lin E; Chen MC; Hsu FN; Shazzad Hossain Prince GM; Chiu KY; Teng CJ; Yang TY; Wang HY; Yue CH; Yu CH; Lai CH; Hsieh JT; Lin H
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31395805
[TBL] [Abstract][Full Text] [Related]
17. Calpain-2/p35-p25/Cdk5 pathway is involved in the neuronal apoptosis induced by polybrominated diphenyl ether-153.
Zhang H; Chang L; Zhang H; Nie J; Zhang Z; Yang X; Vuong AM; Wang Z; Chen A; Niu Q
Toxicol Lett; 2017 Aug; 277():41-53. PubMed ID: 28559121
[TBL] [Abstract][Full Text] [Related]
18. N-acetylcysteine prevents beta-amyloid toxicity by a stimulatory effect on p35/cyclin-dependent kinase 5 activity in cultured cortical neurons.
Hsiao YH; Chen PS; Yeh SH; Lin CH; Gean PW
J Neurosci Res; 2008 Sep; 86(12):2685-95. PubMed ID: 18512759
[TBL] [Abstract][Full Text] [Related]
19. Cyclin-dependent kinase 5 represses Foxp3 gene expression and Treg development through specific phosphorylation of Stat3 at Serine 727.
Lam E; Choi SH; Pareek TK; Kim BG; Letterio JJ
Mol Immunol; 2015 Oct; 67(2 Pt B):317-24. PubMed ID: 26198700
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase Czeta regulates Cdk5/p25 signaling during myogenesis.
de Thonel A; Ferraris SE; Pallari HM; Imanishi SY; Kochin V; Hosokawa T; Hisanaga S; Sahlgren C; Eriksson JE
Mol Biol Cell; 2010 Apr; 21(8):1423-34. PubMed ID: 20200223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
